Asia & Oceania Cannabis Industry & Marijuana Business News aurora cannabis Australia Canadian Medical Marijuana & Cannabis Industry News Cann Group Cannabis Industry & Marijuana Business Briefs International Marijuana Business News

Aurora Cannabis exits Australia’s Cann Group after $28M impairment charge

Alberta-based Aurora Cannabis sold off its stake in Australian medical marijuana company Cann Group, but the Canadian producer still sees promise in the Australian market. “We continue to see growth potential in this important market and will mai…

Asia & Oceania Cannabis Industry & Marijuana Business News Canadian Medical Marijuana & Cannabis Industry News Europe Cannabis Industry & Marijuana Business News Featured Marijuana Business & Cannabis Industry News International Marijuana Business News Latin America Cannabis Industry & Marijuana Business News Marijuana Legalization and Regulatory News for Cannabis Businesses United States Cannabis Industry & Marijuana Business News WHO cannabis scheduling

WHO cannabis recommendations still face uphill battle for adoption

The World Health Organization’s cannabis scheduling recommendations appeared to have limited support at a United Nations Commission on Narcotic Drugs (CND) “intersessional” meeting on Thursday in Vienna. That means the proposals still face an uphill ba…

Asia & Oceania Cannabis Industry & Marijuana Business News Cannabis Industry & Marijuana Business Briefs International Marijuana Business News Medicinal Cannabis Agency New Zealand

New Zealand extends medical cannabis transition to avoid supply disruption

Medical cannabis suppliers in New Zealand have been given an extension on new product-assessment rules that were set to take effect this month. That development came to light in a Medicinal Cannabis Agency (MCA) communication sent to industry stakehold…

Asia & Oceania Cannabis Industry & Marijuana Business News Australia Cannabis Industry & Marijuana Business Briefs International Marijuana Business News Marijuana Industry Statistics, Data and Charts

Australia approves record number of medical cannabis patients

Australia’s medical cannabis market continues to grow. In September, more than 6,000 patients were approved for medical marijuana treatment through the country’s Special Access Scheme (SAS) Category B pathway. That’s the highest monthly gain since 2016…

Asia & Oceania Cannabis Industry & Marijuana Business News Australia Cannabis Industry & Marijuana Business Briefs Epidiolex Epidyolex GW Pharmaceuticals International Marijuana Business News Medical Cannabis Industry & Recreational Marijuana Business News

GW Pharmaceuticals cannabis drug gets regulatory OK in Australia

GW Pharmaceuticals’ plant-derived CBD drug Epidyolex received approval from Australia’s Therapeutic Goods Administration (TGA) to be used in treating seizures related to Lennox-Gastaut syndrome and Dravet syndrome for patients 2 and older. …